BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25862811)

  • 1. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
    Hofbauer SL; Stangl KI; de Martino M; Lucca I; Haitel A; Shariat SF; Klatte T
    Br J Cancer; 2014 Oct; 111(8):1526-31. PubMed ID: 25117808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
    Pichler M; Hutterer GC; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R
    Br J Cancer; 2013 Sep; 109(5):1123-9. PubMed ID: 23922109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Luo C; Xu B; Fan Y; Yu W; Zhang Q; Jin J
    Biomed Res Int; 2017; 2017():3142926. PubMed ID: 28168196
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
    Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
    Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
    Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
    World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
    Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
    Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
    Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
    Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
    J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Serum Uric Acid and Gamma-Glutamyltransferase in Patients with Advanced Gastric Cancer.
    Yang S; He X; Liu Y; Ding X; Jiang H; Tan Y; Lu H
    Dis Markers; 2019; 2019():1415421. PubMed ID: 31885729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
    Parker AS; Eckel-Passow JE; Serie D; Hilton T; Parasramka M; Joseph RW; Wu KJ; Cheville JC; Leibovich BC
    Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
    Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
    Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
    Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
    Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
    PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
    Zhang Q; Jiao X
    Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.
    Dalpiaz O; Krieger D; Ehrlich GC; Pohlmann K; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
    Urol Int; 2017; 98(3):320-327. PubMed ID: 27732981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging.
    Elghiaty A; Kim J; Jang WS; Park JS; Heo JE; Rha KH; Choi YD; Ham WS
    Medicine (Baltimore); 2018 Nov; 97(48):e13433. PubMed ID: 30508956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.